Literature DB >> 6526256

Sequential changes in nuclear DNA content by chemotherapy observed in experimental canine gastric cancer.

K Ochi, K Takeshita, M Sunagawa, H Habu, K Hoshi, N Tanaka.   

Abstract

It is known that the nuclear DNA contents correlate with the grade of malignancy. In this study, nuclear DNA contents of biopsy specimens taken from N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG)-induced canine gastric cancer were measured by Feulgen-DNA-cytofluorometry. The DNA content and histological findings were sequentially observed after weekly administration of 7-N-(p-hydroxyphenyl)-mitomycin C (0.8 mg/kg), a kind of mitomycin C derivative. The appearance rate of cells over 4C decreased remarkably from 18.8% to 9.86% on average (p less than 0.02) and the maximum value of distribution also went down from 9.18C to 7.33C (p less than 0.01) at the early stage of administration of the oncostatic agent when no histological change was yet observable. It might be expected that this procedure will enable the future evaluation of oncostatic effects at the cellular level more objectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6526256     DOI: 10.1007/bf02793871

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  3 in total

Review 1.  DNA in human tumors: a cytophotometric study.

Authors:  N Böhm; W Sandritter
Journal:  Curr Top Pathol       Date:  1975

2.  [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].

Authors:  T Shinkai; N Saijo; K Tominaga; K Eguchi; E Shimizu; M Shibuya; Z Shimabukuro
Journal:  Gan To Kagaku Ryoho       Date:  1983-03

3.  Antitumor activity of 7-N-phenyl derivatives of mitomycin C in the leukemia P388 system.

Authors:  R Imai; T Ashizawa; C Urakawa; M Morimoto; N Nakamura
Journal:  Gan       Date:  1980-08
  3 in total
  1 in total

1.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.